Prevention of coronary heart disease

BMJ 2004; 328 doi: http://dx.doi.org/10.1136/bmj.328.7436.404-a (Published 12 February 2004)
Cite this as: BMJ 2004;328:404.2

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Statins are even less effective than paper shows

  1. David Taylor, general practitioner principal,
  2. Arnold Jenkins, general practitioner principal,
  3. Philipp Conradi, part time general practitioner (pconradi@hotmail.com)
  1. Birmingham B31 2HZ
  2. Burnley BB10 1LG
  3. Birmingham B7 5DT

    EDITOR—Marshall commendably questions current trends in preventive medicine.1 He looks at cost effectiveness of cardioprotective drug treatment, including simvastatin 40 mg, by assessing pooled data from different trials. Treatment effects are balanced with costs. The expenditure for simvastatin 40 mg is calculated as prescribing costs plus additional costs for …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL